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Information on the regional concentrations of angiotensin
(Ang) II and its type-1 and -2 receptors (AT1R, AT2R) in the
kidney is still incomplete. Published data on the levels of
arterially delivered Ang I and II (Ang Ia, Ang IIa) and
intrarenally produced Ang I and II (Ang Ii, Ang IIi) in the renal
vein and in whole tissue were analyzed by using a kinetic
model of Ang production and distribution in the glomerular
and peritubular cortical tissue regions (Glom, Pt). (1) 90% of
Ang II is cell-associated, due to its binding to AT1R and AT2R;
(2) most Ang II in the renal cortex is Ang IIi; (3) Ang IIa is
mainly localized in Glom; (4) Ang Ii rather than Ang Ia is a
substrate of renal angiotensin-converting enzyme; (5) Ang IIi
is localized in Pt and its concentration in interstitial fluid is
5–15 times the Ang II concentration in arterial plasma; and (6)
in Glom the interstitial concentration of cell surface-bound
AT1R is above 200Kd, and in Pt the AT1R and AT2R
concentrations are above 10Kd. In conclusion, endocrine Ang
II mainly acts in Glom, whereas Pt is exposed to paracrine
Ang II generated by the conversion of intrarenally produced
Ang I. High AT1R concentrations in Glom and Pt favor
diffusion-limited binding, so that the apparent binding rate
constant at sites closest to the source of Ang II delivery is
greatly increased. Results may explain why the kidney is
responsive to low levels of endocrine Ang II, despite its high
content of paracrine Ang II.
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Part I of this analysis presents a quantitative model describing
the kinetics of the production, distribution, and disposal of
Ang II in the kidney.1 By using this model it is possible to
calculate, from Ang I and II measurements in blood and in
whole tissue, the Ang I and II concentrations in various tissue
compartments as well as the local AT1 and AT2 receptor
densities. Quantitative information on the concentrations of
Ang I and II and on the concentrations of arterially delivered
and intrarenally produced Ang I and II in renal venous
plasma and in whole tissue is now available, and can be
introduced into the model and analyzed. Here, we describe
the results of this analysis and its implications.
EXPERIMENTAL DATA
A summary of experimental data introduced into the kinetic
model is presented in Tables 1 and 2. The concentrations of
arterially delivered Ang I and II (CIa, CIIa) and intrarenally
produced Ang I and II (CIi, CIIi) were derived from
measurements of intact 125I-Ang I and II and their unlabeled
counterparts in blood plasma and in whole renal cortical
tissue from pigs receiving systemic infusions of 125I-Ang I.2
The infusions were administered to animals treated with an
angiotensin-converting enzyme (ACE) inhibitor or AT1
receptor antagonist as well as to untreated controls. Tables
1 and 2 refer to data obtained under steady-state conditions.
The model-based equations for calculating the local Ang I
and II concentrations and intrarenal AT1 and AT2 receptor
densities also contain, as independent variables, a number of
physical parameters and kinetic constants. For the values of
these variables and for an explanation of the abbreviations
and symbols used in the present paper, we refer to part I of
the analysis.1 Results are expressed as mean and s.e.m., and
are compared by using two-sided Student’s t-test for
unpaired observations.
MODEL-BASED CALCULATIONS
Distribution of Ang II over various intrarenal compartments
As shown in Figure 1, the calculated concentration of
intrarenally produced Ang I in interstitial fluid of the
peritubular region (CIiIsfPt) is 10–50 times the plasma
concentration of Ang I in the renal artery (CIPa), depending
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on the type of treatment of the animals and on the diffusive
clearance across the peritubular capillaries (ClDiffPt), which
ranges from 0.1 to 0.5 ml/min per gram of renal cortex.1 The
concentration of intrarenally produced Ang II in peritubular
interstitial fluid (CIIiIsfPt) is only about 3–15 times the arterial
plasma concentration of Ang II (CIIPa).
Very little Ang II in the kidney originates from intrarenal
conversion of arterially delivered Ang I.3–7 On the other hand,
the CIIiIsfPt/CIiIsfPt ratio is reduced by 80% after the oral
administration of the ACE inhibitor captopril (Figure 2). It
appears therefore that the intrarenal Ang II production, at
least most of it, depends on conversion of intrarenally
produced Ang I by ACE.
Figures 3 and 4 show how arterially delivered (endocrine)
Ang II and intrarenally produced (paracrine) Ang II are
distributed over the different regions and compartments in
the renal cortex. It appears that about 90% of both endocrine
and paracrine Ang II is cell-associated.
Regional AT1 and AT2 receptor concentrations
The calculated concentrations of cell surface AT1 and AT2
receptors in interstitial fluid (CAT1RCsGlom, CAT1RCsPt,
CAT2RCsPt) are presented in Figure 5. Results refer to a
diffusive clearance rate of Ang II across the peritubular
capillaries (ClDiffPt) ranging from 0.1 to 0.5 ml/min. Figure 5
also shows the concentrations of cell-associated Ang IIa in the
glomerular region (CIIaClGlom), expressed as a fraction of the
total concentration of Ang IIa in the renal cortex (CIIaT). The
model implies that most Ang IIi in the renal cortex is
localized in the peritubular compartment. In contrast, at least
70% of Ang IIa appears to be localized in the glomerular
compartment. There are no major differences between
control and captopril-treated animals.
Results indicate that CAT1RCsGlom is more than two orders
of magnitude higher than the equilibrium dissociation
constant, Kd, of the Ang II-AT1 receptor reaction, and that
CAT1RCsPt and CAT2RCsPt are at least one order of magnitude
higher than Kd.
DISCUSSION
Validity of model-based calculations
Results of these calculations depend on the experimental data
presented in Table 1 and 2, as well as on the values of a
Table 1 | Concentrations of arterially delivered Ang I (CIa) and
intrarenally produced Ang I (CIi) in the kidney, expressed
relative to the concentration in blood plasma
Concentration ratios Control Captopril Eprosartan
N=7 N=5 N=5
Vein/artery (CIaPv/CIPa) 0.1570.05 0.1470.04 0.0770.02
Cortex/artery (CIaT/CIPa) (ml/g) 0 0 0
Cortex/vein (CIaT/CIaPv) (ml/g) 0 0 0
Vein/artery (CIiPv/CIPa) 0.8070.16 0.7870.18 1.0070.28
Cortex/vein (CIiT/CIiPv) (ml/g) 1875 1274 2778
Data are mean7s.e.m. and are derived from studies in anesthetized pigs.
Ang I, angiotensin I.
Table 2 | Concentrations of arterially delivered Ang II (CIIa)
and intrarenally produced Ang II (CIIi) in the kidney,
expressed relative to the concentration in blood plasma
Concentration ratios Control Captopril Eprosartan
N=7 N=5 N=5
Vein/artery (CIIaPv/CIIPa) 0.1270.02 0.1870.07 0.0970.02
Cortex/artery (CIIaT/CIIPa) (ml/g) 4.970.6 4.770.6 0.3870.07*
Cortex/vein (CIIaT/CIIaPv) (ml/g) 47710 3376 3.970.5*
Vein/artery (CIIiPv/CIIPa) 0.3070.12 0.2370.06 0.1470.03
Cortex/vein (CIIiT/CIIiPv) (ml/g) 235741 249752 132730*
Data are mean7s.e.m. and are derived from studies in anesthetized pigs.2
*Po0.01 for differences from control and captopril groups.
Ang II, angiotensin II.
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Figure 1 | Bar graphs showing the ratio between the concentra-
tion of intrarenally produced Ang I in peritubular interstitial fluid
and the plasma concentration of Ang I in the renal artery (CIiIsfPt/
CIPa), and the ratio between the interstitial fluid concentration of
intrarenally produced Ang II and the plasma concentration of
Ang II in the renal artery (CIIiIsf/CIIiPa). Calculations were made
using data obtained in anesthetized pigs2 and equations (22)–(24) in
Schalekamp and Danser.1 CIaPv/CIPa in these equations is taken to be
equal to 0.15, as measured in control animals (Table 1). Data refer to
peritubular transcapillary diffusive Ang I and II clearance rates (ClDiffPt)
of 0.1, 0.3, and 0.5 ml/min per gram of renal cortex.1 Open bars:
control; hatched bars: captopril treatment; closed bars: eprosartan
treatment.
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Figure 2 | Effect of ACE inhibition by captopril on the ratio
between the calculated concentration, in peritubular interstitial
fluid, of intrarenally produced Ang II and the concentration of
intrarenally produced Ang I. Calculations were made using data
obtained in anesthetized pigs2 and equations (22)–(24) in Schalekamp
and Danser.1 *Po0.05 for differences from control animals and
animals treated with the AT1 receptor antagonist eprosartan.
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number of physical parameters and kinetic constants. Our
estimates of the AT1 receptor concentration in the peritubular
region (CAT1RCsPt) are based on the effect of eprosartan
treatment on the CIIiT/CIIiPv ratio, with the implicit
assumption that AT1 receptor blockade during this treatment
was complete. If, however, the blockade had been less than
complete, the value of CAT1RCsPt would be higher than
originally calculated. For instance, the model-based calcula-
tions corrected for 50% blockade yield a value of CAT1RCsPt
1.4 times the uncorrected result; for CAT1RCsGlom, however,
the corrected and uncorrected results are practically identical.
The model predicts that the precision of estimates of
CAT1RCsPt can be improved by also examining the effect of
AT2 receptor blockade on CIIiT/CIIiPv.
An alternative way of calculating the regional AT1 receptor
concentrations is to use the equations that depend on
measurements of CIIa rather than CIIi.1 Direct quantitative
information about the regional distribution of Ang IIa can be
obtained from autoradiographic studies, by using radio
labeled Ang II or one of its more stable peptidic analogs.
With such information, the regional receptor concentrations
can be calculated without any knowledge of the concentra-
tions of endogenous Ang II.
Our calculations do not account for the effects of
treatment with ACE inhibitors or AT1 receptor antagonists
on renal plasma flow and filtration fraction. From the
equations used in these calculations it appears that, in view of
the values of other independent variables, the changes in
renal hemodynamics to be expected are too small (i.e.
o10–20%) to invalidate the general conclusion that the
regional concentrations of cell surface AT1 receptors are high
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Figure 3 | Schematic presentation of concentrations of endocrine
Ang II in tissue compartments of the renal cortex. Approximate
values are presented, as calculated from data obtained in
anesthetized pigs.2 Calculations are based on the kinetic model
described in Schalekamp and Danser.1 Glomeruli are assumed to
occupy 5% of the total volume of renal cortex.19
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Figure 4 | Schematic representation of concentrations of
paracrine Ang II in tissue compartments of the renal cortex.
Approximate values are presented, as calculated from data
obtained in anesthetized pigs.2 Calculations are based on the kinetic
model described in Schalekamp and Danser.1 *: at a peritubular
transcapillary diffusive clearance rate of Ang II (ClDiffPt) of,
respectively, 0.5–0.1 ml/min per gram of renal cortex.1
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Figure 5 | Line graphs showing the concentrations of cell surface
AT1 receptors in glomerular and peritubular interstitial fluid
(CAT1RCsGlom, CAT1RCsPt), the concentration of cell surface AT2
receptors in peritubular interstitial fluid (CAT2RCsPt), as a
function of the peritubular transcapillary diffusive clearance rate
of Ang II (ClDiffPt). The amount of arterially delivered Ang II in the
glomerular region, expressed as a fraction of the total amount of
arterially delivered Ang II in the renal cortex (CIIaGlom/CIIaT), is also
shown. Calculations were made by using equations (48)–(53) in
Schalekamp and Danser.1
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enough to keep free Ang II in interstitial fluid at levels not far
above the level in arterial blood plasma.
The very high concentration of cell surface AT1 receptors
in glomerular mesangial interstitial fluid, as calculated in the
present study, is in agreement with measurements of the Ang
II receptor density on isolated rat glomeruli8 and with the
finding that these receptors are mainly of the AT1 type.
9 In
view of the fact that, in the renal cortex, the tubules occupy
most of the volume, the calculated concentration of cell
surface AT1 receptors in cortical peritubular interstitial fluid
is not too much different from estimates obtained in studies
of cultured vascular smooth muscle cells.10
Physiological implications
An important consequence of the high concentrations of
glomerular and peritubular cell surface AT1 receptors in
interstitial fluid (CAT1RCsGlom, CAT1RCsPt) is the quasi-
complete binding of extracellular Ang II. This in turn has
another important consequence, which is related to the
notion that the receptors are not uniformly exposed to Ang
II; receptors close to the source of Ang II delivery ‘see’ the
ligand before the other receptors do. We call this phenom-
enon ‘one-way hormone delivery’, which is comparable to the
‘topological factor’ described by Frelin and Guedin11 with
respect to the binding of endothelin-1 to ETA receptors in
vascular tissue. A high receptor concentration is a prerequi-
site for one-way hormone delivery to cause rapid combina-
tion with the receptors closest to the source of delivery, so
that even a small increase in hormone concentration will
cause a sharp rise of receptor occupancy (fractional
saturation) at this site. Over time, however, this peak of
occupancy will be leveled out as a consequence of dissoci-
ation of the hormone–receptor complex. In order to sustain a
sufficiently high occupancy, re-entry of hormone into the
fluid-phase extracellular microenvironment has to be pre-
vented, and the concentration of unoccupied cell surface
receptors has to be maintained at a high level. Rapid AT1
receptor-mediated endocytosis of Ang II, followed by
recycling of the receptor to the cell surface, is precisely
doing that.
Ang II has to diffuse to the AT1 receptor before it can react
to form the Ang II–AT1 receptor complex. Under conditions
of quasi-complete hormone binding, the intrinsic reaction
rate is high as compared with the rate of diffusion, so that the
overall rate of binding is severely diffusion-limited. Consider,
as an example, a plane vascular smooth muscle tissue sheet
containing one layer of vascular smooth muscle cells
(representing the media layer of a resistance vessel) with an
AT1 receptor concentration of 120 fmol/mg protein.
10 The
volume of 106 cells is about 1ml, the cells occupy 90% of the
total vascular wall volume11 and the protein content of the
cells is about 0.3 g/ml, so that the concentration of AT1
receptors in the vascular interstitial fluid (CAT1RCs) is about
(3.6) 1010 mol/ml or 240Kd.
In case of one-way delivery and quasi-complete binding of
Ang II, the reaction conditions are comparable to the general
case where a diffusing substance is immobilized by a reaction
that proceeds much faster than the diffusion process, so that
at any time a local equilibrium can be assumed to exist
between the concentration of immobilized substance (S) and
the concentration of substance free to diffuse (C). The fixed
relationship between S and C is represented by
S ¼ rC ð1Þ
Allowing for the instantaneous reaction, the standard
equation for diffusion in one dimension is modified as
follows:12
dC=dt ¼ Dd2C=dx2  dS=dt ð2Þ
where x is the distance (normal to the tissue sheet) from the
exposed surface, and D is the diffusion coefficient of the
diffusing substance. From equations (1) and (2), it follows
that
dC=dt ¼ ½D=ðrþ 1Þd2C=dx2 ð3Þ
In effect, the reaction is slowing down the diffusion process
thereby reducing the volume of distribution of the diffusing
substance by the factor rþ 1. Thus, the binding of Ang II to
the AT1 receptors is governed by a modified association rate
constant; the standard value of kass has to be multiplied by
the amplification factor rþ 1, where r approaches a
maximum value as high as CAT1R/Kd, that is, as mentioned,
about 240.
This diffusion-dependent prereceptor amplification me-
chanism may well explain why Ang II, at levels far below Kd,
is capable of eliciting a sustained cell response and why ACE
inhibitors and AT1 receptor antagonists are effective drugs,
even when the extracellular concentration of free Ang II is
low. This mechanism may not apply to the AT2 receptor,
because this type of receptor does not appear to be involved
in specific receptor-mediated endocytosis.13,14 High rates of
AT1 receptor-mediated endocytosis help to minimize the
overflow of locally produced Ang II into the microcircula-
tion, and thereby the transport to sites at some distance from
the site of production.
Our calculations indicate that the bulk of arterially
delivered Ang II is localized in the glomerular tissue region,
which is in accordance with autoradiographic studies after
systemic infusion of 125I-Ang II.15 We also found the
concentration of cell surface AT1 receptors in interstitial
fluid to be higher in glomerular tissue than in peritubular
tissue. The AT1 receptors in the glomerulus are almost
exclusively on mesangial cells, mediating intracellular events
that are important for the regulation of the glomerular
ultrafiltration coefficient (Kf) and thereby the glomerular
filtration rate.9 These findings lend support to the conclusion
that, in the kidney, endocrine Ang II from the circulation
mainly acts in the glomerular region. The receptors in
peritubular tissue appear to be mainly exposed to paracrine
Ang II.
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According to the model-based calculations, paracrine
rather than endocrine Ang I is the most important source
of Ang II in the kidney. As shown in Figure 2, our
calculations of the concentrations of intrarenally produced
Ang I and II in peritubular interstitial fluid (CIiIsfPt, CIIiIsfPt)
in ACE inhibitor-treated animals demonstrated a marked
reduction of the CIIiIsfPt/CIiIsfPt ratio, indicating that
intrarenal Ang II production is highly dependent on ACE.
This is in agreement with measurements of intrarenal Ang II
in mice with reduced ACE gene expression and in wild-type
mice treated with an ACE inhibitor.16 We found a reduced
Ang II/I tissue concentration ratio of the renal cortex in pigs
treated with the ACE inhibitor captopril, but the difference
with controls was not statistically significant (data not
shown). This can be explained by incomplete ACE inhibition
in tissue and/or the existence of alternative converting
enzymes, combined with the fact that only a small fraction
of both Ang I and II in renal tissue is localized in inter-
stitial fluid.
Our analysis is compatible with the view that ACE at the
brush border of proximal tubular cells is the main site of Ang
II production. This site is well suited for one-way Ang II
delivery to the AT1 receptors of efferent glomerular arterioles,
through diffusion into the peritubular interstitium. This view
is in agreement with the fact that, in the human kidney, ACE
is confined to the brush border of proximal tubular cells,17
and with our finding in pigs that conversion of arterially
delivered Ang I does not significantly contribute to the
intrarenal production of Ang II.3,4,6
A model-based analysis of Ang II measurements, like the
one presented here, may help to further clarify the functions
of the intrarenal renin–angiotensin system under normal
conditions and in kidney disease. This type of analysis will
also improve our understanding of the renal actions of drugs
interfering with the renin–angiotensin system, and may help
to better delineate their place in the prevention and treatment
of progressive renal failure related to hypertension, diabetes,
and arteriosclerosis. Ang II assays are still fraught with pit-
falls. Matrix-assisted laser desorption/ionization-time of flight
Ang II detection has the potential to solve this problem.18
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